T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$2.48B |
| 2 |
Kenvue
KVUE
|
+$1.5B |
| 3 |
Halliburton
HAL
|
+$1.12B |
| 4 |
Boeing
BA
|
+$950M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$920M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.64B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Advanced Micro Devices
AMD
|
+$1.66B |
| 4 |
Johnson & Johnson
JNJ
|
+$1.56B |
| 5 |
Amazon
AMZN
|
+$1.17B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.76% |
| 2 | Healthcare | 16.83% |
| 3 | Financials | 10.91% |
| 4 | Consumer Discretionary | 10.77% |
| 5 | Communication Services | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Coty
COTY
$2.42B
| $29.4M | ﹤0.01% |
2,676,124
-152,657
| -5% | -$1.8M |
|
827
StoneX
SNEX
$8.05B
| $29.1M | ﹤0.01% |
1,519,606
+63,489
| +4% | +$1.17M |
|
828
First Industrial Realty Trust
FR
$8.4B
| $28.9M | ﹤0.01% |
607,734
-52,265
| -8% | -$2.69M |
|
829
Xylem
XYL
$28.5B
| $28.7M | ﹤0.01% |
314,885
-1,300
| -0.4% | -$134K |
|
830
Simply Good Foods
SMPL
$968M
| $28.6M | ﹤0.01% |
827,636
-470,002
| -36% | -$16.9M |
|
|
CBAY
831
DELISTED
Cymabay Therapeutics
CBAY
| $28.4M | ﹤0.01% |
1,903,701
+1,809,280
| +1,916% | +$24M |
|
|
DAWN
832
DELISTED
Day One Biopharmaceuticals
DAWN
| $28.3M | ﹤0.01% |
2,308,028
-1,703
| -0.1% | -$22.2K |
|
|
GBIO
833
DELISTED
Generation Bio
GBIO
| $28.3M | ﹤0.01% |
745,470
-3,948
| -0.5% | -$187K |
|
|
XYZ
834
Block Inc
XYZ
$49.9B
| $28.2M | ﹤0.01% |
637,308
-3,651,499
| -85% | -$226M |
|
835
Iron Mountain
IRM
$37B
| $28.2M | ﹤0.01% |
474,443
-1,106
| -0.2% | -$67.6K |
|
836
Immunovant
IMVT
$8.8B
| $28M | ﹤0.01% |
730,042
+710,514
| +3,638% | +$16.1M |
|
|
VMW
837
DELISTED
VMware, Inc
VMW
| $28M | ﹤0.01% |
168,141
+42,371
| +34% | +$6.79M |
|
838
Natera
NTRA
$45.5B
| $27.9M | ﹤0.01% |
630,413
-95,466
| -13% | -$4.87M |
|
839
Crocs
CROX
$6.36B
| $27.8M | ﹤0.01% |
315,342
-119,626
| -28% | -$12.3M |
|
840
Commercial Metals
CMC
$7.98B
| $27.7M | ﹤0.01% |
561,290
+493,629
| +730% | +$26.8M |
|
841
Array Technologies
ARRY
$796M
| $27.3M | ﹤0.01% |
1,229,996
+388,053
| +46% | +$8.43M |
|
842
Eversource Energy
ES
$27.2B
| $27.2M | ﹤0.01% |
467,728
-2,467
| -0.5% | -$164K |
|
843
Sana Biotechnology
SANA
$1.1B
| $27.2M | ﹤0.01% |
7,026,141
+1,902,713
| +37% | +$10.2M |
|
844
Immuneering
IMRX
$336M
| $27.1M | ﹤0.01% |
3,533,322
-47,423
| -1% | -$436K |
|
|
IGMS
845
DELISTED
IGM Biosciences
IGMS
| $27.1M | ﹤0.01% |
3,242,715
+11,845
| +0.4% | +$100K |
|
|
PWSC
846
DELISTED
PowerSchool Holdings, Inc.
PWSC
| $26.9M | ﹤0.01% |
1,185,685
+34,690
| +3% | +$760K |
|
847
Brown & Brown
BRO
$23.8B
| $26.8M | ﹤0.01% |
383,998
+1,411
| +0.4% | +$101K |
|
848
Hilton Grand Vacations
HGV
$3.49B
| $26.7M | ﹤0.01% |
656,697
-56,262
| -8% | -$2.48M |
|
849
Cirrus Logic
CRUS
$6.11B
| $26.7M | ﹤0.01% |
360,869
-965
| -0.3% | -$75.4K |
|
|
SPNS
850
DELISTED
Sapiens International
SPNS
| $26.6M | ﹤0.01% |
936,139
-29,573
| -3% | -$846K |
|
Similar funds
T. Rowe Price Associates's Q3 2023 Portfolio in Review
As of Q3 2023, T. Rowe Price Associates held 2,959 positions worth $682B, down 4.9% from $718B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 4.7%. T. Rowe Price Associates opened 69 new positions and exited 71, leaving the 2,959-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2023 buy was Maplebear: 6,435,942 shares worth $191M.
- T. Rowe Price Associates added most to SLB Ltd in Q3 2023, an estimated $2.48B increase.
- T. Rowe Price Associates's biggest Q3 2023 reduction was Microsoft, cutting an estimated $2.64B.
- T. Rowe Price Associates fully exited Life Storage, Inc. in Q3 2023, selling an estimated $285M.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $682B portfolio in Q3 2023.
- T. Rowe Price Associates opened 69 new positions and closed 71 in Q3 2023.
- T. Rowe Price Associates's portfolio value fell 4.9% quarter-over-quarter to $682B.
Based on T. Rowe Price Associates's 13F filing for Q3 2023, filed 14 Nov 2023.